Business Wire

Amarna Therapeutics Raises €10 million to Progress lead Development Candidate into Clinical Trials and Appoints a new Supervisory Board

LEIDEN, the Netherlands--(BUSINESS WIRE)--Amarna Therapeutics, a privately held biotechnology company developing a next-generation SV40-based gene delivery vector platform named SVac that promises to ...
Yahoo Finance

Amarna Therapeutics and NorthX Biologics Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy Toward Clinical Trials for Type 1 Diabetes

Leiden, The Netherlands, 8th July 2025 - Amarna Therapeutics, ("Amarna" or "the Company"), a privately held biotechnology company pioneering transformative gene therapies, today announced the ...
Yahoo Finance

Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease

The Phenocell-Amarna collaboration aims to assess a groundbreaking gene therapy approach for Dry AMD based on Amarna’s SV40-derived Nimvec™ gene delivery vector platform combined with Phenocell’s ...